Higher vs Standard Adalimumab Induction Dosing Regimens and Two Maintenance Strategies: Randomized SERENE CD Trial Results

Geert R. D'Haens*, William J. Sandborn, Edward V. Loftus, Stephen B. Hanauer, Stefan Schreiber, Laurent Peyrin-Biroulet, Remo Panaccione, Julián Panés, Filip Baert, Jean Frederic Colombel, Marc Ferrante, Edouard Louis, Alessandro Armuzzi, Qian Zhou, Venkata S. Goteti, Nael M. Mostafa, Thao T. Doan, Joel Petersson, Tricia Finney-Hayward, Alexandra P. SongAnne M. Robinson, Silvio Danese

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

47 Scopus citations

Fingerprint

Dive into the research topics of 'Higher vs Standard Adalimumab Induction Dosing Regimens and Two Maintenance Strategies: Randomized SERENE CD Trial Results'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry